CIK 0001253689 · Non-accelerated filer<br>Smaller reporting company
CRESCENT BIOPHARMA, INC.
Sign in to watch- Ticker
- CBIO
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- Cayman Islands
- Entity type
- operating
- Phone
- 617-430-5595
- Business address
- 300 FIFTH AVENUE, WALTHAM, MA, 02451
- Former names
- GLYCOMIMETICS INC
- ARS Other Annual Report to Security Holders
- DEF 14A Proxy Proxy Statement
- 3 Insider Initial Statement of Ownership
- 3 Insider Initial Statement of Ownership
- S-8 Other Securities Offered to Employees in Benefit Plans
- 8-K Event Results of operations
- 10-K Report Annual Report
- 8-K Event Regulation FD disclosure
- 8-K Event Regulation FD disclosure
- 4 Open-market buy 10% owner bought 100,000 shares at $1.70 ($170,000)
- 4 Open-market buy 10% owner bought 400,000 shares at an average $1.78 ($712,255)
- 8-K Event Executive or director change
- 4 Open-market buy 10% owner bought 1,515,266 shares at an average $2.00 ($3,027,929)
- 4 Open-market buy 10% owner bought 11,451 shares at $3.24 ($37,123)
- 3 Insider Initial Statement of Ownership
- SC 13G Stake Amended Statement of Ownership
- SC 13D/A Stake Beneficial Ownership Report
- 5 Insider Annual Insider Trading Report
- 4 Option exercise Director acquired 10,500 shares (option exercise)
- 4 Open-market sale 10% owner sold 3,652,016 shares at an average $3.14 ($11,484,515)
Page 13 of 34 · 678 filings